Everett Harris & CO Johnson & Johnson Transaction History

Everett Harris & CO

$8 Billion
Q3 2024

A detailed history of Everett Harris & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Everett Harris & CO holds 527,847 shares of JNJ stock, worth $81.9 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

527,847

Previous 534,584 1.26%

Holding current value

$81.9 Million

Previous $78.1 Million 9.48%

% of portfolio

1.07%

Previous 1.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$145.48 - $167.38 $980,098 - $1.13 Million	-6,737 Reduced 1.26%	527,847 $85.5 Million
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $2.41 Million - $2.64 Million	-16,725 Reduced 3.03%	534,584 $78.1 Million
Q1 2024 Apr 19, 2024	SELL	$155.22 - $162.74 $1.3 Million - $1.36 Million	-8,351 Reduced 1.49%	551,309 $87.2 Million
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $2.45 Million - $2.68 Million	-16,853 Reduced 2.92%	559,660 $87.7 Million
Q3 2023 Oct 23, 2023	SELL	$155.75 - $174.48 $5.31 Million - $5.95 Million	-34,110 Reduced 5.59%	576,513 $89.8 Million
Q2 2023 Jul 26, 2023	SELL	$154.35 - $166.11 $27.9 Million - $30 Million	-180,659 Reduced 22.83%	610,623 $101 Million
Q1 2023 Apr 24, 2023	SELL	$151.05 - $180.26 $6.11 Million - $7.29 Million	-40,464 Reduced 4.86%	791,282 $123 Million
Q4 2022 Jan 20, 2023	SELL	$160.2 - $179.79 $2.49 Million - $2.8 Million	-15,561 Reduced 1.84%	831,746 $0
Q3 2022 Oct 21, 2022	SELL	$161.33 - $179.52 $2.68 Million - $2.99 Million	-16,628 Reduced 1.92%	847,307 $138 Million
Q2 2022 Jul 22, 2022	SELL	$168.19 - $186.01 $2.7 Million - $2.98 Million	-16,040 Reduced 1.82%	863,935 $153 Million
Q1 2022 Apr 22, 2022	SELL	$158.14 - $179.59 $418,754 - $475,554	-2,648 Reduced 0.3%	879,975 $156 Million
Q4 2021 Feb 02, 2022	SELL	$155.93 - $173.01 $138,153 - $153,286	-886 Reduced 0.1%	882,623 $151 Million
Q3 2021 Nov 03, 2021	SELL	$161.5 - $179.47 $689,443 - $766,157	-4,269 Reduced 0.48%	883,509 $143 Million
Q2 2021 Jul 29, 2021	SELL	$159.48 - $171.07 $346,231 - $371,392	-2,171 Reduced 0.24%	887,778 $146 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $1.75 Million - $1.95 Million	-11,425 Reduced 1.27%	889,949 $146 Million
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $1.03 Million - $1.18 Million	7,483 Added 0.84%	901,374 $142 Million
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $284,409 - $311,659	2,026 Added 0.23%	893,891 $133 Million
Q2 2020 Jul 29, 2020	BUY	$128.81 - $155.51 $566,119 - $683,466	4,395 Added 0.5%	891,865 $125 Million
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $7.45 Million - $10.3 Million	67,056 Added 8.17%	887,470 $116 Million
Q4 2019 Jan 27, 2020	BUY	$127.5 - $146.44 $828,112 - $951,127	6,495 Added 0.8%	820,414 $120 Million
Q3 2019 Nov 06, 2019	BUY	$126.95 - $142.14 $2.24 Million - $2.51 Million	17,645 Added 2.22%	813,919 $105 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $389,384 - $428,248	-2,969 Reduced 0.37%	796,274 $111 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $11.9 Million - $13.2 Million	-94,647 Reduced 10.59%	799,243 $112 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $3.07 Million - $3.7 Million	-25,017 Reduced 2.72%	893,890 $115 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.84 Million - $2.16 Million	-15,111 Reduced 1.62%	918,907 $127 Million
Q2 2018 Jul 27, 2018	SELL	$119.4 - $131.76 $682,132 - $752,744	-5,713 Reduced 0.61%	934,018 $113 Million
Q1 2018 Apr 20, 2018	BUY	$125.1 - $148.14 $3.53 Million - $4.18 Million	28,246 Added 3.1%	939,731 $120 Million
Q4 2017 Feb 01, 2018	SELL	$131.22 - $143.62 $272,019 - $297,724	-2,073 Reduced 0.23%	911,485 $127 Million
Q3 2017 Oct 11, 2017	BUY	$129.47 - $135.38 $118 Million - $124 Million	913,558	913,558 $119 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Johnson & Johnson Transaction History